Two gene therapies for hemophilia available: Now what?
dc.contributor.author | Pierce, Glenn F. | |
dc.contributor.author | Herzog, Roland W. | |
dc.contributor.department | Pediatrics, School of Medicine | |
dc.date.accessioned | 2024-07-16T13:31:04Z | |
dc.date.available | 2024-07-16T13:31:04Z | |
dc.date.issued | 2023 | |
dc.eprint.version | Final published version | |
dc.identifier.citation | Pierce GF, Herzog RW. Two gene therapies for hemophilia available: Now what?. Mol Ther. 2023;31(4):919-920. doi:10.1016/j.ymthe.2023.03.001 | |
dc.identifier.uri | https://hdl.handle.net/1805/42251 | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | |
dc.relation.isversionof | 10.1016/j.ymthe.2023.03.001 | |
dc.relation.journal | Molecular Therapy | |
dc.rights | Publisher Policy | |
dc.source | PMC | |
dc.subject | Hemophilia A | |
dc.subject | Hemophilia B | |
dc.subject | Genetic therapy | |
dc.title | Two gene therapies for hemophilia available: Now what? | |
dc.type | Article | |
ul.alternative.fulltext | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124068/ |